Skip to main content
PBH logo

PBH · Prestige Consumer Healthcare Inc. · Webcasts, Transcripts & Audio

Track PBH — free
Market Cap
$2.29B
Shares
47.40M
Volume · Nov 17 597.86K Avg daily vol (3M) 572.29K

Prestige Consumer Healthcare Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Prestige Consumer Healthcare Inc. (PBH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY27 · Q2
2026-11-05
Prestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call Transcript
Balanced tone Breathe Right and Licorium acquisitions ClearEyes supply disruptions and guidance cut GI brands and GLP-1 demand
Revenue
$336.31M
▲ 22.7% YoY
Diluted EPS
$0.53
▼ 38.4% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-10
Prestige Consumer Healthcare Inc. (PBH) September 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
Prestige Consumer Healthcare Inc. (PBH) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
Prestige Consumer Healthcare Inc. (PBH) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY27 · Q1
2026-08-06
Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript
Confident tone Acquisitions (Breathe Right and Locorium Health) ClearEyes recovery and Pillar 5 facility Capital allocation and free cash flow
Revenue
$265.71M
▲ 6.5% YoY
Diluted EPS
$0.61
▼ 35.8% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Prestige Consumer Healthcare Inc. (PBH) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-08
Prestige Consumer Healthcare Inc. (PBH) June 8, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2026-05-14
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call
Positive tone Fiscal 26 results ClearEyes / iCare supply chain recovery Pending M&A - Breathe Right and LeClorian
Revenue
$281.62M*
▼ 5% YoY
Gross margin
51.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-20
Prestige Consumer Healthcare Inc. (PBH) March 20, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-02-05
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Positive tone ClearEyes supply recovery Capital allocation and shareholder returns Diverse business model and channel mix
Revenue
$283.44M
▼ 2.4% YoY
Diluted EPS
$0.97
▼ 20.5% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-06
Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript
Positive tone Clear Eyes supply constraints and recovery DenTek brand and dental guards Gross margin and tariffs
Revenue
$274.11M
▼ 3.4% YoY
Diluted EPS
$0.86
▼ 21.1% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-07
Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript
Cautious tone Clear Eyes / Eye Care Supply Shortfall Pillar5 Acquisition Q1 Financial Results
Revenue
$249.53M
▼ 6.6% YoY
Diluted EPS
$0.95
▼ 3.1% YoY
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-05-08
Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript
Positive tone Capital allocation and leverage Innovation pipeline Marketing agility and brand portfolio
Revenue
$296.52M*
▲ 7% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-06
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript
Confident tone Capital allocation and balance sheet GI category growth (Dramamine, Fleet, Gaviscon) Clear Eyes supply chain constraints recovery
Revenue
$290.32M
▲ 2.7% YoY
Diluted EPS
$1.22
▲ 15.1% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-07
Prestige Consumer Healthcare Inc. (PBH) Q2 2025 Earnings Call Transcript
Positive tone Capital allocation and leverage Canadian portfolio Gross margin and inflation
Revenue
$283.79M
▼ 0.9% YoY
Diluted EPS
$1.09
▲ 1.9% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-08-08
Prestige Consumer Healthcare Inc. (PBH) Q1 2025 Earnings Call Transcript
Positive tone Supply chain and Clear Eyes disruption Hydralyte international growth Gross margin and cost pressure
Revenue
$267.14M
▼ 4.4% YoY
Diluted EPS
$0.98
▼ 7.5% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-05-14
Prestige Consumer Healthcare Inc. (PBH) Q4 2024 Earnings Call Transcript
Cautious tone Supply chain disruptions Capital allocation and balance sheet Manufacturing and supply chain continuity
Revenue
$276.99M*
▼ 3.1% YoY
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-08
Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript
Confident tone Leverage and Debt Reduction Ear & Eye Care Category Growth Gross Margin and Cost Management
Revenue
$282.74M
▲ 2.6% YoY
Diluted EPS
$1.06
▲ 1.9% YoY
Gross margin
55.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-02
Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript
Revenue
$286.32M
▼ 1% YoY
Diluted EPS
$1.07
▲ 4.9% YoY
Gross margin
55.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-03
Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript
Revenue
$279.31M
▲ 0.8% YoY
Diluted EPS
$1.06
▼ 2.8% YoY
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-05-04
Prestige Consumer Healthcare Inc. (PBH) Q4 2023 Earnings Call Transcript
Revenue
$285.87M*
▲ 7.1% YoY
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-02
Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript
Revenue
$275.52M
▲ 0.4% YoY
Diluted EPS
$1.04
▲ 5.1% YoY
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-03
Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript
Revenue
$289.27M
▲ 4.7% YoY
Diluted EPS
$1.02
▲ 14.6% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-04
Prestige Consumer Healthcare Inc. (PBH) Q1 2023 Earnings Call Transcript
Revenue
$277.06M
▲ 2.9% YoY
Diluted EPS
$1.09
▼ 4.4% YoY
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-05-05
Prestige Consumer Healthcare Inc. (PBH) Q4 2022 Earnings Call Transcript
Revenue
$266.94M*
▲ 12.3% YoY
Gross margin
55.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-03
Prestige Consumer Healthcare Inc. (PBH) Q3 2022 Earnings Call Transcript
Revenue
$274.47M
▲ 14.9% YoY
Diluted EPS
$0.99
▲ 22.2% YoY
Gross margin
56.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-04
Prestige Consumer Healthcare Inc. (PBH) Q2 2022 Earnings Call Transcript
Revenue
$276.23M
▲ 16.3% YoY
Diluted EPS
$0.89
▲ 1.1% YoY
Gross margin
57.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-05
Prestige Consumer Healthcare Inc. (PBH) Q1 2022 Earnings Call Transcript
Revenue
$269.18M
▲ 17.3% YoY
Diluted EPS
$1.14
▲ 32.6% YoY
Gross margin
59.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-05-06
Prestige Consumer Healthcare Inc. (PBH) Q4 2021 Earnings Call Transcript
Revenue
$237.76M*
▼ 5.4% YoY
Gross margin
57.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-04
Prestige Consumer Healthcare Inc. (PBH) Q3 2021 Earnings Call Transcript
Revenue
$238.79M
▼ 1.1% YoY
Diluted EPS
$0.81
▲ 8% YoY
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-05
Prestige Consumer Healthcare Inc. (PBH) Q2 2021 Earnings Call Transcript
Revenue
$237.42M
▼ 0.3% YoY
Diluted EPS
$0.88
▲ 35.4% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-08-06
Prestige Consumer Healthcare Inc. (PBH) Q1 2021 Earnings Call Transcript
Revenue
$229.39M
▼ 1.2% YoY
Diluted EPS
$0.86
▲ 32.3% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-05-07
Prestige Consumer Healthcare Inc. (PBH) Q4 2020 Earnings Call Transcript
Revenue
$251.24M
▲ 4.2% YoY
Diluted EPS
$0.73
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-02-06
Prestige Consumer Healthcare Inc. (PBH) Q3 2020 Earnings Call Transcript
Revenue
$241.55M
▲ 0.1% YoY
Diluted EPS
$0.75
▲ 2.7% YoY
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Date not confirmed
Prestige Consumer Healthcare Inc. (PBH) Q1 2020 Earnings Call Transcript
Revenue
$232.15M
▼ 8.6% YoY
Diluted EPS
$0.65
▲ 0% YoY
Gross margin
57.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–35 of 35 webcasts
Key facts CIK 1295947 CUSIP 74112D101 13F (30d) 340 filings 314 filers Visit website Investor relations